Kestra Medical Technologies (KMTS) Price to Sales (2025 - 2026)
Kestra Medical Technologies' (KMTS) quarterly Price to Sales came in at 42.24 in Q2 2026, up 23.07% year-over-year from 34.32 in Q2 2025, and down 27.95% quarter-over-quarter from 58.63 in Q1 2026.
Powered by 
Analysis
Kestra Medical Technologies (KMTS) Price to Sales (2025 - 2026) Analysis & Trends
Kestra Medical Technologies (KMTS) has reported Price to Sales for 2 consecutive years, with 42.24 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Price to Sales rose 23.07% year-over-year to 42.24 in Q2 2026; TTM through Apr 2026 was 12.72, a 28.6% increase from a year earlier, with the FY2026 full-year figure at 12.72, up 28.6% from the prior year.
- Price to Sales was 42.24 for Q2 2026 at Kestra Medical Technologies, down from 58.63 in the prior quarter.
- Over five years, Price to Sales peaked at 62.43 in Q4 2025 and troughed at 34.32 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn |
| 10 | Kestra Medical Technologies | 1.28 Bn | 925.25 Mn | 15.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 42.24 |
| Jan 31, 2026 | 58.63 |
| Oct 31, 2025 | 62.43 |
| Jul 31, 2025 | 43.74 |
| Apr 30, 2025 | 34.32 |